Reports

Ideas That Generate Results

Genetic Testing Market Outlook to 2017

Genetic Testing Market Outlook to 2017

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : May, 2013| No. of Pages : 140

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1200.00  720.00
CD-ROM Mail Delivery
US$ 1300.00  780.00
Hard Copy Mail Delivery
US$ 1300.00  780.00
Electronic Access - Multi-User License
US$ 1700.00  1020.00

A recent report, “Genetic Testing Market Outlook to 2017”, provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principles and types are covered in around a 140-page report. On account of our analysis of the past and present market trends; drivers; and existing strengths and challenges; forecast for genetic testing has been drawn, according to which, the market is likely to grow at a CAGR of around 9% during 2012-2017.

Our report is an outcome of extensive interaction with industry experts which has led us to portray the updated status of genetic testing in various therapeutic areas, major geographies and significant industry applications. The genetic testing industry has seen several new product launches, active research innovations, strategic activities, launch of new DTC tests, and wider therapeutic applications.

The report effectively illustrates the role of genetic testing in diseases such as Cancer, Cystic Fibrosis, and Alzheimer. It also incorporates the information on disease prevalence, available tests, and genes that cause a particular disease. An extensive research and reliable statistics in terms of market size, developments and future performance for emerging sectors namely, Next-Generation Sequencing, Whole Genome Sequencing, Non Invasive Prenatal Diagnostics, and Personalized Medicine have been covered in the report.

Genetic testing is growing in both developing and developed nations with both industry and research personnel highlighting the significance of molecular biology. The report provides comprehensive analytics of key developments for major markets including the U.S., Europe and Asian countries, and their market overview. Country level analysis depicts the level of penetration for genetic testing, types of tests available, consumer perspectives, regulatory stringency and future growth.

The report also profiles the twelve most active genetic testing market players worldwide: Abbott Laboratories, Roche Diagnostics, Myriad Genetics, Life Technologies, Genomic Health, Sequenom, Transgenomic, Dako, Gen-Probe, Quest Diagnostics, Genoptix and Clarient. For the purpose of effective competitive analysis of the market, these companies have been analyzed in five major areas namely: business overview, product offerings; financial performance for the last three years, strategic analysis and recent developments.

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.